Found 14112 matching trials
EEG Prediction and Clinical Efficacy of tDCS in Fibromyalgia.
NAThe purpose of this randomized controlled trial is to investigate the non-i...
Location
Hospital ClΓnico Universitario de Valencia
Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
PHASE2The purpose of this study is to determine whether Valacyclovir treatment, a...
Location
Helen Schneider Hospital for Women
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
PHASE2This study compares the safety and effectiveness of giving rivogenlecleucel...
Location
TriStar Bone Marrow Transplant, LLC
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
PHASE1This is a pilot, explorative, study to test the feasibility and safety of s...
Location
Unit of Oncology - Ospedali Riuniti of Bergamo
The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects
PHASE1A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Location
The First Hospital of Jilin University
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
PHASE2In this phase II trial, the investigators overarching goal is to demonstrat...
Location
University of Washington
Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement
PHASE2Evaluate the efficacy, safety and tolerability of a single intraoperative d...
Location
Alabama Clinical Therapeutics, LLC
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
PHASE4The study aims to investigate the olfactory TDI score (Threshold, Discrimin...
Location
St. Joseph's Health Care
A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis
PHASE2The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center